Cargando…

Impact of Patient Adherence to Stool-Based Colorectal Cancer Screening and Colonoscopy Following a Positive Test on Clinical Outcomes

Colorectal cancer–screening models commonly assume 100% adherence, which is inconsistent with real-world experience. The influence of adherence to initial stool-based screening [fecal immunochemical test (FIT), multitarget stool DNA (mt-sDNA)] and follow-up colonoscopy (after a positive stool test)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fendrick, A. Mark, Fisher, Deborah A., Saoud, Leila, Ozbay, A. Burak, Karlitz, Jordan J., Limburg, Paul J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2021
Materias:	Research Briefs
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974412/ https://www.ncbi.nlm.nih.gov/pubmed/34021023 http://dx.doi.org/10.1158/1940-6207.CAPR-21-0075

Ejemplares similares

Life-years gained resulting from screening colonoscopy compared with follow-up colonoscopy after a positive stool-based colorectal screening test
por: Mark Fendrick, A., et al.
Publicado: (2022)

Cost-Effectiveness of Waiving Coinsurance for Follow-Up Colonoscopy after a Positive Stool-Based Colorectal Screening Test in a Medicare Population
por: Fendrick, A. Mark, et al.
Publicado: (2022)

Estimating the impact of differential adherence on the comparative effectiveness of stool-based colorectal cancer screening using the CRC-AIM microsimulation model
por: Piscitello, Andrew, et al.
Publicado: (2020)

Impact of Eliminating Cost-Sharing by Medicare Beneficiaries for Follow-Up Colonoscopy After a Positive Stool-based Colorectal Cancer Screening Test
por: Fendrick, A. Mark, et al.
Publicado: (2023)

Impact of screening and follow‐up colonoscopy adenoma sensitivity on colorectal cancer screening outcomes in the CRC‐AIM microsimulation model
por: Fisher, Deborah A., et al.
Publicado: (2020)

Comparison of Simulated Outcomes Between Stool- and Blood-Based Colorectal Cancer Screening Tests
por: Fendrick, A. Mark, et al.
Publicado: (2023)

Cost-Effectiveness of Outreach Strategies for Stool-Based Colorectal Cancer Screening in a Medicaid Population
por: Karlitz, Jordan J., et al.
Publicado: (2022)

Cross-sectional adherence with the multi-target stool DNA test for colorectal cancer screening in a medicaid population
por: Miller-Wilson, Lesley-Ann, et al.
Publicado: (2022)

Cross-sectional adherence with the multi-target stool DNA test for colorectal cancer screening in a large, nationally insured cohort
por: Miller-Wilson, Lesley-Ann, et al.
Publicado: (2021)

Adherence to fecal immunochemical test screening among adults at average risk for colorectal cancer
por: Fisher, Deborah A., et al.
Publicado: (2021)

Out-of-Pocket Costs for Colonoscopy After Noninvasive Colorectal Cancer Screening Among US Adults With Commercial and Medicare Insurance
por: Fendrick, A. Mark, et al.
Publicado: (2021)

Multitarget Stool DNA Screening in Clinical Practice: High Positive Predictive Value for Colorectal Neoplasia Regardless of Exposure to Previous Colonoscopy
por: Eckmann, Jason D., et al.
Publicado: (2020)

Comparison of Screening Colonoscopy Rates After Positive Noninvasive Testing for Colorectal Cancer in States With and Without Cost-Sharing
por: Barthold, Douglas, et al.
Publicado: (2022)

Utilization of a Colorectal Cancer Screening Test Among Individuals With Average Risk
por: Fisher, Deborah A., et al.
Publicado: (2021)

What do ‘false-positive’ stool tests really mean? Data from the New Hampshire colonoscopy registry
por: Butterly, Lynn F., et al.
Publicado: (2023)

Follow-up colonoscopy after an abnormal stool-based colorectal cancer screening result: analysis of steps in the colonoscopy completion process
por: Coronado, Gloria D., et al.
Publicado: (2021)

Alaska Native Patient and Provider Perspectives on the Multitarget Stool DNA Test Compared With Colonoscopy for Colorectal Cancer Screening
por: Redwood, Diana G., et al.
Publicado: (2019)

Improving compliance to colorectal cancer screening using blood and stool based tests in patients refusing screening colonoscopy in Germany
por: Adler, Andreas, et al.
Publicado: (2014)

Stool-Based Colorectal Cancer Screening Test Performance Characteristics in Those With and Without Hemorrhoids
por: Ebner, Derek W., et al.
Publicado: (2023)

Colonoscopy Colorectal Cancer Screening Programme in Southern Iraq: Challenges, Knowledge Gaps and Future Potential
por: Alrubaiy, Laith, et al.
Publicado: (2023)

Factors associated with adherence to colonoscopy among individuals who were positive in the preliminary screening for colorectal neoplasms
por: Li, Ji‐Bin, et al.
Publicado: (2022)

Cross-sectional adherence with the multi-target stool DNA test for colorectal cancer screening: Real-world data from a large cohort of older adults
por: Weiser, Emily, et al.
Publicado: (2020)

Serrated Polyp Yield at Colonoscopy in Patients with Positive FIT, Positive mt-sDNA, and Colonoscopy Only: Data from the New Hampshire Colonoscopy Registry
por: Anderson, Joseph C., et al.
Publicado: (2023)

Provider-perceived barriers to patient adherence to colorectal cancer screening
por: Zhu, Xuan, et al.
Publicado: (2021)

Colonoscopy for Colorectal Cancer Screening
por: Young, Patrick E., et al.
Publicado: (2013)

Evaluation of a Screening Method for the Detection of Colistin-Resistant Enterobacteriaceae in Stool
por: Turbett, Sarah E, et al.
Publicado: (2019)

Stool Microbiota Diversity Analysis of Blastocystis-Positive and Blastocystis-Negative Individuals
por: Stensvold, Christen Rune, et al.
Publicado: (2022)

Rates of Follow-up Colonoscopy After a Positive Stool-Based Screening Test Result for Colorectal Cancer Among Health Care Organizations in the US, 2017-2020
por: Mohl, Jeff T., et al.
Publicado: (2023)

Three-Year Interval for the Multi-Target Stool DNA Test for Colorectal Cancer Screening: A Longitudinal Study
por: Imperiale, Thomas F., et al.
Publicado: (2023)

Motivating Factors Associated With Receipt of Asymptomatic Colonoscopy Screening
por: Basch, Corey H., et al.
Publicado: (2015)

Motives for non-adherence to colonoscopy advice after a positive colorectal cancer screening test result: a qualitative study
por: Bertels, Lucinda, et al.
Publicado: (2020)

Provider- and System-Level Barriers and Facilitators to Colonoscopy and Multi-Target Stool DNA for Colorectal Cancer Screening in Rural/Remote Alaska Native Communities
por: Redwood, Diana, et al.
Publicado: (2023)

Calibration and Validation of the Colorectal Cancer and Adenoma Incidence and Mortality (CRC-AIM) Microsimulation Model Using Deep Neural Networks
por: Vahdat, Vahab, et al.
Publicado: (2023)

Healthcare Provider Perspectives on Lowering Colorectal Cancer Screening Initiation Age to 45 Years: Results From a Survey of Clinicians in the U.S.
por: Rutten, Lila J. Finney, et al.
Publicado: (2020)

An Evolutionary Algorithm to Personalize Stool-Based Colorectal Cancer Screening
por: van Duuren, Luuk A., et al.
Publicado: (2022)

Molecular stool testing as an alternative for surveillance colonoscopy: a cross-sectional cohort study
por: van Lanschot, Meta C. J., et al.
Publicado: (2017)

Colonoscopy Findings in FIT(+) and mt-sDNA(+) Patients versus in Colonoscopy-only Patients: New Hampshire Colonoscopy Registry Data
por: Anderson, Joseph C., et al.
Publicado: (2022)

Colonoscopy education delivered via the patient portal does not improve adherence to scheduled first-time screening colonoscopy
por: Keswani, Rajesh N., et al.
Publicado: (2020)

Colorectal screening among average risk individuals in the United States, 2015–2018
por: Engel-Nitz, Nicole M., et al.
Publicado: (2022)

Stool energy density is positively correlated to intestinal transit time and related to microbial enterotypes
por: Boekhorst, Jos, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uj3mon0fv3duvs6fvmjbuj5ls3